{"id":"W2979711603","doi":"10.1186/s40880-019-0405-5","title":"Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Institutes of Health Research","funders":"Renji Hospital; Science and Technology Commission of Shanghai Municipality; Pfizer","keywords":"Sunitinib; Sorafenib; Axitinib; Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Neoadjuvant therapy; Radiation therapy; Tyrosine-kinase inhibitor; Cancer; Breast cancer; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000248243,0.0004852189,0.001404188,0.0002281799,0.0003006314,0.00004075609,0.0005145619,0.0003846446,0.00005860157],"category_scores_gemma":[0.00005958,0.0004255182,0.0001838808,0.0002048047,0.0005753064,0.00006427999,0.0003235266,0.001395938,0.000004328531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003477452,"about_ca_system_score_gemma":0.0004026316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001359607,"about_ca_topic_score_gemma":0.0001909485,"domain_scores_codex":[0.9975689,0.0003197706,0.0007693729,0.0006184325,0.0003633428,0.0003601568],"domain_scores_gemma":[0.9952698,0.000907176,0.0006706929,0.002534794,0.0005063027,0.0001112838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002552366,0.003516665,0.8086506,0.001028341,0.001639133,0.00005879115,0.01667221,0.000008909942,0.001506499,0.00008566929,0.1570505,0.007230339],"study_design_scores_gemma":[0.01834616,0.006213566,0.8266866,0.0005474722,0.001733885,0.0000269021,0.00200053,0.0001444424,0.001765651,0.00005538919,0.1418519,0.0006275426],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9100972,0.02400179,0.00001397063,0.05445262,0.0001153404,0.007116432,0.0005144417,0.0000477123,0.00364046],"genre_scores_gemma":[0.9847983,0.002593896,0.0005721654,0.008177374,0.0003276388,0.0009762883,0.0009465979,0.0001097503,0.001497965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07470109,"threshold_uncertainty_score":0.9998196,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08029438110833828,"score_gpt":0.3685204662015316,"score_spread":0.2882260850931934,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}